Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin

Biologic therapies targeting B-cells are emerging as an effective strategy to treat a variety of immune-mediated diseases. One of the most studied B-cell-targeted therapies is rituximab, an anti-CD20 monoclonal antibody that exemplifies B-cell depletion therapy and has served as the prototype for ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Sophia, Nedosekin, Dmitry, Wong, Henry K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838371/
https://www.ncbi.nlm.nih.gov/pubmed/36630066
http://dx.doi.org/10.1007/s40257-022-00751-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838371/
https://www.ncbi.nlm.nih.gov/pubmed/36630066
http://dx.doi.org/10.1007/s40257-022-00751-7

Ejemplares similares